Home / Agencies / DOJ / 2026-10379
Proposed Rule

Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products

Agency
DOJ
Document Number
2026-10379
Published
May 26, 2026
Effective Date
-

Abstract

The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer available and/or the company that applied for the exemption no longer exists. If finalized, these products would be removed from DEA's Table of Exempted Prescription Products list, and they would no longer be considered exempt prescription products under the Controlled Substances Act. This action will not impact exempted prescription products with active NDC numbers.

Federal Register Source

This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.

View Full Text on FederalRegister.gov →

Opens in new tab · federalregister.gov

Frequently Asked Questions

What is the 2026-10379 Federal Register document?
Document 2026-10379 is a Proposed Rule published by the Department of Justice in the Federal Register on May 26, 2026. The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer available and/or the company that applied for the exemption no longer exists. If finalized, these products would be removed from DEA's Table of Exempted Prescription Products list, and they would no longer be considered exempt prescription products under the Controlled Substances Act. This action will not impact exempted prescription products with active NDC numbers. View the original at https://www.federalregister.gov/documents/2026/05/26/2026-10379/schedules-of-controlled-substances-removal-of-exemption-status-for-inactive-butalbital-products.
Is document 2026-10379 an economically significant rule?
No. Document 2026-10379 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.

Other Rules from DOJ

Counter-UAS Authority for State, Local, Tribal, and Territorial Law Enforcement and Correctional Agencies
Final Rule · Jul 2026
Licensee “eZ Check” Verification for Transfers; Withdrawing Direct Final Rule
Final Rule · Jul 2026
Fingerprint and Photograph Requirements for Firearms Applications
Proposed · Jul 2026
Registering NFA Firearms That Fall Out of Government Contract
Proposed · Jul 2026
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Proposed · Jul 2026
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Proposed · Jul 2026
View all Department of Justice rules →

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official state legislatures, IAPP, NCSL, and federal regulatory trackers. See our methodology for details. Retrieved and formatted by PlainRegWatch Editorial

Every figure on PlainRegWatch is rendered directly from state source data, no number is typed in by an editor. This page draws directly on federal and state source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.